“Il faut continuer à poser des questions” patient reported outcome measures in cystic fibrosis: An anthropological perspective
- 26 February 2021
- journal article
- research article
- Published by Elsevier BV in Journal of Cystic Fibrosis
- Vol. 20 (6), e108-e113
- https://doi.org/10.1016/j.jcf.2021.02.009
Abstract
No abstract availableKeywords
Funding Information
- Boehringer Ingelheim
- Chiesi Farmaceutici
- GlaxoSmithKline
- Novartis
- AstraZeneca
- Pfizer
This publication has 27 references indexed in Scilit:
- Systematic Evaluation of the Patient-Reported Outcome (PRO) Content of Clinical Trial ProtocolsPLOS ONE, 2014
- A systematic review of patient reported factors associated with uptake and completion of cardiovascular lifestyle behaviour changeBMC Cardiovascular Disorders, 2012
- “This is the Best Fatal Illness That You Can Have”Qualitative Health Research, 2011
- Measuring health-related quality of life in clinical trials in cystic fibrosisJournal of Cystic Fibrosis, 2011
- Chronic diseases influence major life changing decisions: a new domain in quality of life researchJournal of the Royal Society of Medicine, 2011
- Changes in Pediatric Health-Related Quality of Life in Cystic Fibrosis After IV Antibiotic Treatment for Pulmonary ExacerbationsJournal of Clinical Psychology in Medical Settings, 2009
- “I’ve Never Not Had it So I Don’t Really Know What it’s Like Not to”: Nondifference and Biographical Disruption Among Children and Young People With Cystic FibrosisQualitative Health Research, 2009
- Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groupsInternational Journal for Quality in Health Care, 2007
- Patient-reported Outcomes in Cystic FibrosisProceedings of the American Thoracic Society, 2007
- Patient‐reported outcomes and health‐related quality of life in effectiveness studies: pros and consDrug Development Research, 2006